Carmen Gil

Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications

Screening of candidate antiparasitic drugs against Sparicotyle chrysophrii: A phenotypic drug discovery approach.

Screening of candidate antiparasitic drugs against Sparicotyle chrysophrii: A phenotypic drug discovery approach.

Journal: Veterinary parasitology
Published: June 18, 2026

Selective Brain-Penetrant TTBK1 Inhibitors Modulate TDP-43 Pathology and Rescue Cognitive Deficits in a Mouse Model of TDP-43 Proteinopathy.

Selective Brain-Penetrant TTBK1 Inhibitors Modulate TDP-43 Pathology and Rescue Cognitive Deficits in a Mouse Model of TDP-43 Proteinopathy.

Journal: Journal of medicinal chemistry
Published: June 14, 2026

Synthetic Small Molecules as Regulators of In Vitro Multiplication in Selenicereus Hybrids.

Synthetic Small Molecules as Regulators of In Vitro Multiplication in Selenicereus Hybrids.

Journal: Plants (Basel, Switzerland)
Published: May 27, 2026

Corrigendum to "VP3.15 reduces acute cerebellum damage after germinal matrix-intraventricular hemorrhage of the preterm newborn" [Biomed. Pharmacother. 180 (2024) 117586].

Corrigendum to "VP3.15 reduces acute cerebellum damage after germinal matrix-intraventricular hemorrhage of the preterm newborn" [Biomed. Pharmacother. 180 (2024) 117586].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 16, 2026

Innovative therapies under clinical development for ALS treatment: small molecules.

Innovative therapies under clinical development for ALS treatment: small molecules.

Journal: Expert opinion on investigational drugs
Published: April 28, 2026

Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases.

Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases.

Journal: Journal of medicinal chemistry
Published: March 16, 2026

From fragments to drugs: How AI and in silico methods accelerate fragment-to-lead optimization.

From fragments to drugs: How AI and in silico methods accelerate fragment-to-lead optimization.

Journal: European journal of medicinal chemistry
Published: February 10, 2026

AI-assisted fragment-based drug discovery of SARS-CoV-2 macrodomain binders validated by NMR and X-ray crystallography.

AI-assisted fragment-based drug discovery of SARS-CoV-2 macrodomain binders validated by NMR and X-ray crystallography.

Journal: Communications chemistry
Published: January 21, 2026

Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.

Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.

Journal: Neuropharmacology
Published: October 04, 2025

Discovery of a brain penetrant SGK1 inhibitor using a ligand- and structure-based virtual screening methodology.

Discovery of a brain penetrant SGK1 inhibitor using a ligand- and structure-based virtual screening methodology.

Journal: Journal of enzyme inhibition and medicinal chemistry
Published: August 29, 2025

From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability.

From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability.

Journal: Journal of medicinal chemistry
Published: May 17, 2025

MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers.

MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers.

Journal: Neurobiology of disease
Published: January 22, 2025
Showing 1-12 of 109

Last Updated: 09/26/2026